(Novartis)

	NVS latest price $48.1000 (0.42%) ($47.9600 - $48.2300) on Thu. Feb. 23, 2006.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.01% (three month average)
RSI	42
Latest Price	$48.1000(0.42%)
Stocks Behave Similarly	Similar Stock List
Weekly Trend	NVS declines -0.5% a week on average for past two weeks.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support NVS advance at 0% a week (0% probability)   EWG(56%)    SPY(56%)    EWI(52%)    EWP(51%)    XLP(51%)
Factors Impacting NVS price	NVS will decline at least -0.505% in a week (0% probabilities).   TLT(-17%)    SHY(-6%)    TIP(-2%)    REMX(-0%)    GLD(10%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.505% (StdDev 1.01%)
Hourly BBV	0 ()
Intraday Trend	0.1%

1 - 5 Day Possible Target	$46.59(-3.14%)
Resistance Level	$48.41
5 Day Moving Average	$48.1(0%)
10 Day Moving Average	$48.11(-0.02%)
20 Day Moving Average	$48.41(-0.64%)
To recent high	-3.1%
To recent low	5.4%
Market Cap	$110.1b

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

getNextHourMoveProbability failed